Semaglutide
Semaglutide is used in FDA-approved prescription products for chronic weight management in eligible patients. Treatment requires medical evaluation and ongoing clinical oversight.
Learn About SemaglutidePeptideDoc provides personalized medical weight-management care based on individual health history, metabolic factors, lifestyle, clinical goals, and physician evaluation.
PeptideDoc provides a structured clinical program for NYC Tri-State residents seeking individualized medical weight care with direct physician oversight at our Bayside, NY hub.
MD consultation required in the Bayside office.
Direct MD Supervision
503A/503B Network
Cold-Chain
Bayside Hub
4232 Francis Lewis Blvd
Treatment Options
Semaglutide is used in FDA-approved prescription products for chronic weight management in eligible patients. Treatment requires medical evaluation and ongoing clinical oversight.
Learn About SemaglutideTirzepatide is used in FDA-approved prescription products for chronic weight management in eligible patients. Treatment decisions depend on medical history, contraindications, treatment goals, and physician evaluation.
Learn About TirzepatideAdditional FDA-approved prescription options for chronic weight management exist and may be considered depending on the individual patient, such as liraglutide, naltrexone/bupropion, phentermine/topiramate, and orlistat.
See the full overviewTreatment recommendations depend on individual medical evaluation, eligibility, contraindications, FDA-approved indications, and physician judgment. Compare options in semaglutide vs. tirzepatide, or learn about physician-supervised peptide therapy.
Core Philosophy
Sustainable medical weight care should not be reduced to algorithmic, assembly-line prescribing. Dr. Maslavi evaluates the individual behind the data, integrating medical history, diagnostic findings, lifestyle, tolerance, and response into each clinical decision.
Section 01
Patient care begins with an individualized consultation with Dr. Saul Maslavi, MD, including medical history, current medications, goals, risks, and clinical eligibility.
Relevant endocrine, metabolic, hepatic, and renal markers are reviewed directly to support clinically grounded treatment decisions and appropriate monitoring.
Progress, tolerance, laboratory findings, and changing health needs remain under physician oversight throughout the active care journey.
Section 02
A comprehensive treatment plan that may include evaluation for FDA-approved GLP-1 or GIP/GLP-1 therapies when indicated, alongside high-protein nutrition, movement, and behavioral support.
An individualized wellness framework focused on recovery, body composition, metabolic resilience, and healthy aging. Recommendations remain evidence-informed and medically supervised.
Section 03
When pharmacy coordination is clinically appropriate, PeptideDoc works within lawful 503A/503B channels with cGMP-aligned controls and certificate-of-analysis transparency.
Dr. Maslavi reviews contraindications, medication-specific risks, and family history, including thyroid C-cell tumor risks where relevant, before treatment authorization.
Temperature-sensitive medication handling is coordinated through qualified pharmacy and delivery partners with cold-chain safeguards and patient storage education.
Prescription treatment is appropriate only for patients who meet clinical criteria and should be used under the supervision of a qualified healthcare professional. FDA-approved indications only; no dosing instructions are provided on this page.
Bayside Hub
In-person physician evaluation is anchored at PeptideDoc in Bayside, NY. Telehealth may support permitted follow-up and education, while treatment decisions remain subject to medical evaluation, licensure, and clinical appropriateness.
Clinical Roadmap
Comprehensive medical history, medication reconciliation, baseline metrics, and relevant laboratory review.
An individualized care plan based on clinical findings, treatment eligibility, lifestyle, and sustainable health goals.
Physician-managed treatment progression when clinically appropriate, with tolerance and side effects carefully reviewed.
Progress assessment using agreed health markers, laboratory findings, body-composition measures, and patient-reported response.
A long-term plan that supports nutrition, activity, metabolic health, and continued medical follow-up.
Shared Accountability
| Clinical Area | Patient Commitment | Dr. Maslavi & Clinical Support |
|---|---|---|
| Biometric Tracking | Record agreed measurements, symptoms, and treatment response consistently. | Interpret trends, assess clinical significance, and adjust the care plan when appropriate. |
| Lab Compliance | Complete requested laboratory testing within the recommended review window. | Review results directly and identify safety, metabolic, endocrine, hepatic, or renal considerations. |
| Nutritional Adherence | Follow the individualized nutrition framework and communicate barriers honestly. | Align nutritional guidance with treatment goals, medical needs, and sustainable behavior change. |
Bayside Only
Meet directly with Dr. Maslavi to review your health history, diagnostic needs, clinical eligibility, and personalized weight-management goals.
Schedule An AppointmentMD consultation required in the Bayside office.
Educational content only. Prescription treatment is appropriate only for patients who meet clinical criteria and should be used under the supervision of a qualified healthcare professional. FDA-approved indications only. No dosing instructions. Saul F. Maslavi, MD · NPI 1134137383 · 4232 Francis Lewis Boulevard, Bayside, NY 11361.